Intuitive Surgical has seen its stock move sharply over recent years, and the question now is whether the current share price lines up with the cash flows that the business is expected to generate. With fresh news around procedure trends and a major legal settlement still in focus, the valuation conversation is squarely about what investors are paying for those future cash streams.
- Over the past 3 years the stock has returned about 71%, which puts a lot of emphasis on whether the underlying cash generation can support that kind of share price climb.
- Recent updates on procedure growth, pricing and a US$450m settlement charge all feed directly into expectations for future margins and the timing of cash flows that underpin any valuation work on Intuitive Surgical.
- If you'd rather focus on earnings, this one's for you. See why Intuitive Surgical's 52.0x P/E tells a different valuation story.
The issue now is whether today's market value for Intuitive Surgical is justified by what its cash flows suggest the business is intrinsically worth.
Alongside weighing Intuitive Surgical's cash flows and the recent settlement charge, it can be helpful to benchmark ideas against a focused list such as 36 healthcare AI stocks.
Does Intuitive Surgical Look Fairly Valued on Cash Flow?
The Discounted Cash Flow (DCF) model here focuses on what Intuitive Surgical can return to shareholders through future free cash. Latest twelve month free cash flow sits at about $3.1b, and analyst projections reflect higher cash generation over the next decade, with forecast free cash flows moving into the mid to high single digit billions in dollar terms.
Those assumptions are based on Intuitive Surgical continuing to scale procedure volumes and systems, while also absorbing items like the recent US$450m settlement charge. Because the Q3 2026 update highlighted slower U.S. procedure growth and pricing pressure in markets such as China, the fact that the DCF outcome still lands broadly in line with the current $443.85 share price indicates that the market is already incorporating some of those risks. Find out what Intuitive Surgical could be worth using our Discounted Cash Flow (DCF) estimate.
The Intuitive Surgical Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Intuitive Surgical pick up where the DCF puzzle leaves off. They spell out which assumptions on Intuitive Surgical's growth, profitability and earnings power would need to hold for the share price to sit meaningfully above or below today's market level, and each one treats fair value as a hypothesis about the business that can be tracked over time rather than a one off snapshot.
Community views on Intuitive Surgical split between a strong business that looks fairly priced on cash flows and a setup that already bakes in a lot of optimism.
Bull case: 17% undervalued
"ISRG’s robust business model and strong moat come from this recurring revenue, as hospitals must continuously purchase instruments, maintenance services, and software updates..."
Discover why this Narrative puts Intuitive Surgical at 17% undervalued.
Bear case: 37% overvalued
"Bearish analysts expect Intuitive Surgical to experience sustained margin pressure as pricing competition, policy headwinds and new robotic entrants compress returns on its growing installed base..."
Explore why this Narrative puts Intuitive Surgical at 37% overvalued.
One more piece of the Intuitive Surgical puzzle
Price and cash flows tell only part of the story for Intuitive Surgical, because the people setting priorities and how they are rewarded can tilt long term outcomes in very different directions. See who runs Intuitive Surgical and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com